Shanghai Rongsheng Biological Reagent Factory was founded in October 1988 at No.185 Huajing Road, Shanghai, with a capital of 150,000 RMB and 8 employees.
In November 1989, Rongsheng's first product "Hemagglutination Method for Hepatitis B Surface Reagent Kit" was launched.
In June 1990, Rongsheng passed the first batch of rectification and acceptance of diagnostic reagent enterprises by the Ministry of Health, and obtained the "Drug Manufacturing License".
In May 1994, Rongsheng launched the new generation of "TRUST" card kit.
June 1995, "Shanghai Rongsheng Bio-technology Co., Ltd." was formally established at No. 99 Huafa Road, Shanghai, according to the new "Company Law", and the capital was expanded to 26 million yuan.
July, 1995, Rongsheng launched "Immediate Knowledge" EIA method to detect Hepatitis B virus "two half" and anti-HCV enzyme immunoassay kit.
In June 1996, Rongsheng passed the evaluation of Shanghai Science and Technology Commission and became one of the first batch of "Shanghai High-tech Enterprises".
In May 1998, the patent of "Comb Spot Immunoassay Kit" was approved, Patent No.: ZL97 2 34216.8.
October 1998, the 10th anniversary of the founding of Rongsheng, the scale of the company has developed to 2500m2 of factory building (including purification workshop of 500m2), capital of 36 million yuan, 71 employees, and a total of 1,000,000 employees. capital of 36 million yuan, 71 employees, more than 40 kinds of products, the output value of that year exceeded 60 million yuan.
June 2000, Rongsheng and the United States launched the BIORESUN series of automatic biochemical analyzers special biochemical reagents (reagents)
October 2001, Rongsheng successfully passed the U.S. NSF international consulting and certification bodies of the company's ISO9002 quality system certification, and obtained export license.
January, 2002, Rongsheng factory passed the certification of "Good Manufacturing Practice (GMP)" of the State Food and Drug Administration of China, which set a new milestone for Rongsheng.
August 2002, Rongsheng international fourth generation of "semi-automatic, general automatic biochemistry special liquid single-type reagents" new market.
December 2002, Rongsheng formally set up "Rongsheng Technology Center", and hired Chinese-American scientists as the company's CSO and director of the technology center, making R & D personnel accounted for 20% of the total number of employees.
In March, 2003, Rongsheng founded the quarterly magazine "Rongsheng Tide" to examine the whole industry from the perspective of an enterprise, and to lead the first wind of an industry with a unique style.
October 2003, Rongsheng ISO9002 quality management system was successfully upgraded to ISO9001:2000 version.
December 2003, Rongsheng joint the National Health Industry Enterprise Management Association, China Medical Laboratory Branch, the Ministry of Health Clinical Examination Center, Health News successfully held the first "Rongsheng Cup" China Medical Laboratory Knowledge Contest.
March 2004, the first one-year validity of Hepatitis B "two half" reagent kit was launched on the market.
In May 2004, Rongsheng's HIV (1+2) production successfully passed the GMP (Good Manufacturing Practice) certification, and the company obtained the second GMP certificate.
July 2004, as the first major achievement since the establishment of the company's technology center, potassium and sodium enzyme assay kits were successfully developed and put into production.AFU, GPDA, 5'-NT, ADA kits were successfully developed.
October 2004, the company was awarded the 2003 Contract Credit Enterprise Certificate issued by Shanghai Administration for Industry and Commerce, and the 2003 Contract Credit Grade AA Certificate issued by Shanghai Contract Credit Promotion Association.
December 2004, Rongsheng biochemical reagent production quality management system passed the Shanghai Municipal Food and Drug Administration medical device production enterprise quality management system assessment and acceptance, and obtained the medical device production enterprise quality system assessment report.
In August, 2005, HCV increased the package specification of 48 and 576 human doses, and the product was upgraded to one year validity period.
October, 2005, HIV increased 48 copies, 576 copies of specifications, one-year validity. 48 copies of HCV, HBV576 copies of official production. 96 copies of HIV was used in the national winter conscription of nearly 20 provinces physical examination reagents. Biochemical product registration certificate has completed the transition from trial production to permitted production. The number of medical device registration certificates reached 54.
February 2006, the patent of "Enzyme Labeling Plate with Adsorption" was approved, Patent No.: ZL 2004 2 011449.0.
April 2006, the diagnostic kits (ELISA) for HAV-IgM and HBcAb-IgM were increased to 96 person-counts. Specification, one year validity. The original "trial" production of registered products have become quasi-production of registered products. Hepatitis B Virus Surface Antibody, Surface Antigen Diagnostic Kit and Syphilis Toluidine Red Unheated Serum Test Diagnostic Kit were awarded the certificate of "2005 Famous and Excellent Product" in Shanghai Pharmaceutical Industry.
August, 2006, serum potassium and sodium ions enzymatic determination reagents and methods "invention patent through the State Intellectual Property Office (Application No. 2006100284511 and 2006100284526)" review qualified. Rongsheng Company was awarded the Certificate of Enterprise of Keeping Contracts and Keeping Credit for 2004-2005 issued by Shanghai Administration for Industry and Commerce, and the Certificate of AAA Grade of Contract Credit Rating for 2004-2005 issued by Shanghai Contract Credit Promotion Association.
In November 2006, "Rongsheng" brand in vitro diagnostic reagents were recommended by Shanghai Small and Medium-sized Enterprises Brand Building Promotion Committee as "2006 Brand Products".
January, 2007, HIV antibody diagnostic reagent kit was awarded the second place in the 2006 national quality evaluation.
July 2007, Rongsheng Biologicals inaugurated its new site: 50 acres of garden-style factory, with a building area of 35,000 square meters, more than 10,000 square meters of GMP workshop, dedicated quality control technology building, laboratory animal center.
August 2007, Rongsheng was awarded the certificate of "Integrity Unit of Labor and Social Security" by Shanghai Xuhui District Labor Association.
October 2007, Rongsheng was awarded the 2006 AAA Certificate of Contract Credit Rating issued by Shanghai Contract Credit Promotion Association.
In December 2007, we were awarded the certificates of "Excellent Innovative Enterprise" and "Honest Enterprise" in Shanghai's biomedical industry.
January 2008, Rongsheng passed the GMP certificate of the new factory after relocation, and the HIV antibody diagnostic kit was awarded the first place in the 2007 national quality assessment.
September 2008, "Shanghai Rongsheng Bio-Pharmaceutical Co.
October 2008, the company was awarded the 2007 Contract Credit Grade AAA Certificate issued by Shanghai Contract Credit Promotion Association. 2006-2007 Contract and Credit Keeping Enterprise Certificate issued by Shanghai Administration for Industry and Commerce.
In November 2008, "Rongsheng" brand in vitro diagnostic reagents were recommended by Shanghai Small and Medium-sized Enterprises Brand Building Promotion Committee as "2008 Brand Products".
In January 2009, Rongsheng trademark was recognized as "Shanghai Famous Trademark" by Shanghai Administration for Industry and Commerce.